Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Ivosidenib in refractory or relapsed IDH1-mutated Acute Myeloid Leukemia patients in real life settings: The ivoobs observational study from the french AML intergroup ALFA/filo

Blood (2025) 146 (Supplement 1): 3455.

https://doi.org/10.1182/blood-2025-3455

Published: 2025

Journal Articles

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Nicoletta Colombo, Raffaella Grasso, Maurizio Miglino, Marino Clavio, Gianmatteo Pica, MD, Germana Beltrami, Micaela Bergamaschi, Carlo Marani, Antonia Cagnetta, Anna Ghiso, Laura Mitscheunig, Ivana Pierri, Filippo Ballerini, Letizia Canepa, Sara Aquino, Enrico De Astis, Angelo Michele Carella, Marco Gobbi

Blood (2009) 114 (22): 4675.

https://doi.org/10.1182/blood.V114.22.4675.4675

Published: 2009

Journal Articles

Finding of Kinase Domain Mutations at Diagnosis IN PATIENTS with Chronic PHASE Chronic Myeloid Leukemia (CP-CML) MAY Identify Those at High RISK of Disease Progression.

Angelo Michele Carella, Gabriella Cirmena, Gioacchino Catania, Gianmatteo Pica, Germana Beltrami, Alberto Ballestrero, Franco Patrone, Anna Garuti

Blood (2009) 114 (22): 4251.

https://doi.org/10.1182/blood.V114.22.4251.4251

Published: 2009

Journal Articles

Peripheral Stem Cell Mobilization with Chemotherapy + G-CSF Priming in a Large Series of Patients with Lymphoma Candidates to Autologous Transplantation. An Analysis of Baseline and Ongoing Predictors of Failure or Suboptimal Stem Cell Collection.

Enrico Morello, MD, Camillo Almici, MD, Luca Arcaini, MD, Liliana Baushi, MD, Barbara Botto, MD, Andrea Castelli, MD, Annamaria Nosari, MD, Gianmatteo Pica, MD, Francesco Ripamonti, MD, Flavia Salvi, MD, Angelo Michele Carella, Prof, Gianluca Gaidano, MD, PhD, Alessandro Levis, MD, Enrica Morra, MD, Umberto Vitolo, MD, Rossi Giuseppe, MD

Blood (2009) 114 (22): 2149.

https://doi.org/10.1182/blood.V114.22.2149.2149

Published: 2009

Journal Articles

Has the Incidence of Extramedullary Disease Changed with the New Therapeutic Approaches? Analysis of a Cohort of 965 Multiple Myeloma (MM) Patients (pts).

Marzia Varettoni, MD, Alessandro Corso, MD, Gianmatteo Pica, MD, Patrizia Zappasodi, MD, Silvia Mangiacavalli, MD, Cristiana Pascutto, Mario Lazzarino

Blood (2007) 110 (11): 4749.

https://doi.org/10.1182/blood.V110.11.4749.4749

Published: 2007

Journal Articles

Bisphosphonates and Osteonecrosis of the Jaw: Advantages of a New Schedule.

Patrizia Zappasodi, MD, Alessandro Corso, MD, Marzia Varettoni, MD, Catherine Klersy, MD, Gianmatteo Pica, MD, Silvia Mangiacavalli, MD, Mario Lazzarino, MD

Blood (2006) 108 (11): 3590.

https://doi.org/10.1182/blood.V108.11.3590.3590

Published: 2006

Journal Articles

Modification of Cytokine Levels and CD34+ Stem Cell Adhesion Molecules during Mobilization in Multiple Myeloma (MM) Patients.

Patrizia Zappasodi, MD, Alessandro Corso, MD, Chiara Rusconi, MD, Mara De Amici, Erica Consensi, Cristiana Pascutto, Marzia Varettoni, MD, Silvia Mangiacavalli, MD, Gianmatteo Pica, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 5068.

https://doi.org/10.1182/blood.V106.11.5068.5068

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Ivosidenib in refractory or relapsed IDH1-mutated Acute Myeloid Leukemia patients in real life settings: The ivoobs observational study from the french AML intergroup ALFA/filo

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Finding of Kinase Domain Mutations at Diagnosis IN PATIENTS with Chronic PHASE Chronic Myeloid Leukemia (CP-CML) MAY Identify Those at High RISK of Disease Progression.

Peripheral Stem Cell Mobilization with Chemotherapy + G-CSF Priming in a Large Series of Patients with Lymphoma Candidates to Autologous Transplantation. An Analysis of Baseline and Ongoing Predictors of Failure or Suboptimal Stem Cell Collection.

Has the Incidence of Extramedullary Disease Changed with the New Therapeutic Approaches? Analysis of a Cohort of 965 Multiple Myeloma (MM) Patients (pts).

Bisphosphonates and Osteonecrosis of the Jaw: Advantages of a New Schedule.

Modification of Cytokine Levels and CD34+ Stem Cell Adhesion Molecules during Mobilization in Multiple Myeloma (MM) Patients.

Email alerts

ASH Publications

American Society of Hematology

Update search

Ivosidenib in refractory or relapsed IDH1-mutated Acute Myeloid Leukemia patients in real life settings: The ivoobs observational study from the french AML intergroup ALFA/filo

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Finding of Kinase Domain Mutations at Diagnosis IN PATIENTS with Chronic PHASE Chronic Myeloid Leukemia (CP-CML) MAY Identify Those at High RISK of Disease Progression.

Peripheral Stem Cell Mobilization with Chemotherapy + G-CSF Priming in a Large Series of Patients with Lymphoma Candidates to Autologous Transplantation. An Analysis of Baseline and Ongoing Predictors of Failure or Suboptimal Stem Cell Collection.

Has the Incidence of Extramedullary Disease Changed with the New Therapeutic Approaches? Analysis of a Cohort of 965 Multiple Myeloma (MM) Patients (pts).

Bisphosphonates and Osteonecrosis of the Jaw: Advantages of a New Schedule.

Modification of Cytokine Levels and CD34+ Stem Cell Adhesion Molecules during Mobilization in Multiple Myeloma (MM) Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only